Gene · 5345
Papers4,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia. | Blood Adv | 2023 | 36044391 | PubTator, text mining | PubMed |
| Prothrombinex®-VF in chronic liver disease: Friend or foe? | Emerg Med Australas | 2023 | 35993256 | PubTator, text mining | PubMed |
| Impact of digital technologies upon teaching and learning in higher education in Latin America: an outlook on the reach, barriers, and bottlenecks. | Educ Inf Technol (Dordr) | 2023 | 35992366 | PubTator, text mining | PubMed |
| Predictors of olfactory improvement after endoscopic sinus surgery in chronic rhinosinusitis with nasal polyps. | J Laryngol Otol | 2023 | 35791849 | PubTator, text mining | PubMed |
| The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease. | Haematologica | 2023 | 35484648 | PubTator, text mining | PubMed |
Performance evaluation of thrombus molecular markers thrombomodulin, thrombin-antithrombin complex, plasmin-α2-plasmin inhibitor complex, and tissue plasminogen activator-inhibitor complex by a chemiluminescence analyzer. | Hippokratia | 2022 | 37188051 | PubTator, text mining | PubMed |
| Comparison of Fragments in Human Hemostatic Proteins That Mimics Fragments in Proteins of A/H1N1 Viruses and Coronaviruses. | Mol Gen Microbiol Virol | 2022 | 36968805 | PubTator, text mining | PubMed |
| Clinical study on the feasibility of new thrombus markers in predicting massive cerebral infarction. | Front Neurol | 2022 | 36761916 | PubTator, text mining | PubMed |
| Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi. | Front Cardiovasc Med | 2022 | 36741833 | PubTator, text mining | PubMed |
| Danger signals in traumatic hemorrhagic shock and new lines for clinical applications. | Front Physiol | 2022 | 36726379 | PubTator, text mining | PubMed |
| Identifying and validating molecular subtypes of biliary atresia using multiple high-throughput data integration analysis. | Front Immunol | 2022 | 36713418 | PubTator, text mining | PubMed |
| Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis. | Front Mol Biosci | 2022 | 36710882 | PubTator, text mining | PubMed |
| Small extracellular vesicles from mesenchymal stem cells: A potential Weapon for chronic non-healing wound treatment. | Front Bioeng Biotechnol | 2022 | 36704302 | PubTator, text mining | PubMed |
| Mineral Trioxide Aggregate vs Calcium-Enriched Mixture Pulpotomy in Young Permanent Molars with a Diagnosis of Irreversible Pulpitis: A Randomized Clinical Trial. | Iran Endod J | 2022 | 36704084 | PubTator, text mining | PubMed |
| Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction. | JACC Basic Transl Sci | 2022 | 36687271 | PubTator, text mining | PubMed |
Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study. | Ann Transl Med | 2022 | 36618792 | PubTator, text mining | PubMed |
| Temporal Changes in Extracellular Vesicle Hemostatic Protein Composition Predict Favourable Left Ventricular Remodeling after Acute Myocardial Infarction. | Int J Mol Sci | 2022 | 36613770 | PubTator, text mining | PubMed |
| Emerging Role of MicroRNA-30c in Neurological Disorders. | Int J Mol Sci | 2022 | 36613480 | PubTator, text mining | PubMed |
| CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease. | Alzheimers Res Ther | 2022 | 36581878 | PubTator, text mining | PubMed |
| Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells. | Sci Rep | 2022 | 36581641 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5345/papers?page=26